Invention Grant
- Patent Title: Method for proliferation of pancreatic progenitor cells
-
Application No.: US15501703Application Date: 2015-08-03
-
Publication No.: US10590390B2Publication Date: 2020-03-17
- Inventor: Yuya Kunisada
- Applicant: Takeda Pharmaceutical Company Limited
- Applicant Address: JP Osaka
- Assignee: Takeda Pharmaceutical Company Limited
- Current Assignee: Takeda Pharmaceutical Company Limited
- Current Assignee Address: JP Osaka
- Agency: Fish & Richardson P.C.
- Priority: JP2014-158470 20140804
- International Application: PCT/JP2015/072591 WO 20150803
- International Announcement: WO2016/021734 WO 20160211
- Main IPC: C12N5/071
- IPC: C12N5/071

Abstract:
The present invention relates to a method for preparing highly pure pancreatic progenitor cells by using pluripotent stem cells such as ES cells or iPS cells as a source, inducing their differentiation into pancreatic progenitor cells, and culturing and proliferating the pancreatic progenitor cells. Specifically, the present invention relates to a method for proliferation of pancreatic progenitor cells, comprising the step of culturing the pancreatic progenitor cells in a medium containing (i) an EGF signal transduction activator and/or an FGF signal transduction activator and (ii) a ROCK inhibitor.
Public/Granted literature
- US10655105B2 Method for proliferation of pancreatic progenitor cells Public/Granted day:2020-05-19
Information query